Diabetic Kidney Disease



This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 5 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated


Condition:   Diabetic Nephropathies
Interventions:   Drug: BI 690517;   Drug: Eplerenone;   Drug: Placebo
Sponsor:   Boehringer Ingelheim
Not yet recruiting - verified May 2017


Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease


Conditions:   Type 2 Diabetes Mellitus;   Diabetic Kidney Disease
Intervention:   Drug: Jinshuibao Capsule
Sponsor:   Second Xiangya Hospital of Central South University
Not yet recruiting - verified May 2017


Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan


Condition:   Type 2 Diabetic Nephropathy
Interventions:   Drug: Alfacalcidol;   Drug: Irbesartan
Sponsor:   The Third Xiangya Hospital of Central South University
Recruiting - verified May 2017


Clinical Trial of HuangKui Capsule to Treat Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Drug: Placebo drug that simulates Irbesartan tablets;   Drug: irbesartan tablets;   Drug: Placebo drug that simulates HuangKui capsule;   Drug: HuangKui Capsule
Sponsor:   Jiangsu Famous Medical Technology Co., Ltd.
Recruiting - verified December 2016


The Multi-Center Clinical Study of Tang Shen Prescription on Type 2 Diabetic Kidney Disease in Early Stage


Condition:   Diabetic Kidney Disease
Interventions:   Drug: Tangshen Prescription;   Drug: Placebos
Sponsors:   Guang'anmen Hospital of China Academy of Chinese Medical Sciences;   Anhui Provincial Hospital of Traditional Chinese Medicine;   Zhengzhou City Hospital of Traditional Chinese Medicine;   Shijiazhuang City Hospital of Traditional Chinese Medicine;   Baoding City Hospital of Traditional Chinese Medicine;   Hubei Hospital of Traditional Chinese Medicine;   Changchun Hospital of Traditional Chinese Medicine;   Xingtai City Hospital of Traditional Chinese Medicine;   Medicine Zibo Wanjie Tumor Hospital;   Zouping Country Hospital of Traditional Chinese Medicine;   She Country Hospital of Traditional Chinese Medicine;   Beijing Hospital of TCM;   Baishi Hospital
Not yet recruiting - verified January 2017


Resveratrol's Effects in Diabetic Nephropathy


Condition:   Diabetic Nephropathy
Interventions:   Drug: Resveratrol;   Drug: Placebo;   Drug: Losartan
Sponsor:   Shiraz University of Medical Sciences
Recruiting - verified October 2016


Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy


Conditions:   Diabetic Nephropathy;   Albuminuria
Interventions:   Drug: Pirfenidone;   Drug: Placebo
Sponsors:   Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran;   Grupo Medifarma, S. A. de C. V.
Recruiting - verified August 2016


An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy


Condition:   Diabetic Nephropathy
Interventions:   Drug: MT-3995 Low;   Drug: MT-3995 Middle;   Drug: MT-3995 High
Sponsor:   Mitsubishi Tanabe Pharma Corporation
Active, not recruiting - verified February 2017


NEPHSTROM for Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Biological: Mesenchymal Stromal Cells;   Other: Placebo
Sponsors:   Mario Negri Institute for Pharmacological Research;   Leiden University Medical Center;   ASST Papa Giovanni XXIII, Bergamo, Italy;   IRCCS - Istituto di Ricerche Farmacologiche Mario Negri - Bergamo, Italy;   Belfast Health and Social Care Trust;   National University of Ireland, Galway, Ireland;   University Hospital Birmingham, NHS Foundation Trust, Hospital, Birmingham, UK;   NHS Blood and Transplant
Not yet recruiting - verified May 2017


Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Drug: Finerenone (BAY94-8862);   Drug: Placebo
Sponsor:   Bayer
Recruiting - verified May 2017


Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Drug: Finerenone (BAY94-8862);   Drug: Placebo
Sponsor:   Bayer
Recruiting - verified May 2017


Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy


Condition:   Diabetic Nephropathy
Interventions:   Drug: MT-3995 Low;   Drug: MT-3995 Middle;   Drug: MT-3995 High;   Drug: Placebo
Sponsor:   Mitsubishi Tanabe Pharma Corporation
Completed - verified March 2017


Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy


Condition:   Diabetic Nephropathies
Interventions:   Drug: Semi-individualised Chinese Medicine treatment;   Drug: Routine medical care (active comparator)
Sponsors:   The University of Hong Kong;   School of Chinese Medicine, The University of Hong Kong
Recruiting - verified October 2016


Colchicine for Diabetic Nephropathy Trial


Condition:   Diabetic Nephropathies
Interventions:   Drug: Colchicine;   Drug: Placebo
Sponsors:   Sheba Medical Center;   D-Cure, Israel
Recruiting - verified May 2017


Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout


Condition:   Diabetic Nephropathy
Interventions:   Drug: Topiroxostat BID, (Oral daily dosing for 28 weeks);   Drug: Placebo BID, (Oral daily dosing for 28 weeks)
Sponsors:   Sanwa Kagaku Kenkyusho Co., Ltd.;   Fuji Yakuhin Co., Ltd.
Completed - verified November 2015


Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Drug: Selonsertib;   Drug: Placebo to match selonsertib
Sponsor:   Gilead Sciences
Completed - verified January 2017


Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT)


Condition:   Diabetic Kidney Disease
Interventions:   Other: Telephone Reminder;   Other: Doctor-Nurse Follow Up;   Other: Personalized Risk Report for Patient Empowerment
Sponsor:   Asia Diabetes Foundation
Recruiting - verified August 2016


To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy


Condition:   Diabetic Nephropathy
Interventions:   Drug: DW1029M 600mg;   Drug: DW1029M 1200mg;   Drug: Placebo
Sponsor:   Dong Wha Pharmaceutical Co. Ltd.
Completed - verified February 2017


Mechanisms of Diabetic Kidney Disease in American Indians


Conditions:   Nervous System;   Diabetic Kidney Disease;   Diabetes Mellitus, Type 2
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrolling by invitation - verified February 28, 2017


Study Of Diabetic Nephropathy With Atrasentan


Condition:   Diabetic Nephropathy
Interventions:   Drug: Atrasentan;   Drug: Placebo
Sponsor:   AbbVie
Recruiting - verified April 2017


The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Intervention:   Drug: Liraglutide
Sponsors:   Karl Neff;   University College Dublin
Completed - verified July 2016


Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)


Conditions:   Diabetes;   Hypertension;   Diabetic Kidney Disease
Intervention:   Behavioral: Pharmacist telehealth intervention
Sponsor:   Duke University
Active, not recruiting - verified February 2017


Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Drug: BMS-813160;   Drug: Placebo matching with BMS-813160
Sponsor:   Bristol-Myers Squibb
Completed - verified August 2015


Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients


Condition:   Diabetic Nephropathy
Interventions:   Drug: Repository Corticotropin Injection;   Drug: Placebo
Sponsor:   Mallinckrodt
Completed - verified November 2016


Delaying the Progression of Diabetic Nephropathy in Pima Indians


Condition:   Diabetic Nephropathy
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed - verified August 16, 2011

Refine Your Search Advanced Search